This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents. Top assignees: Wisconsin Alumni Research Foundation, The University of Chicago, Leiden University. Active years: 2022-2026.
Company Filing History:
3 out of 4,226 
2 out of 959 
1 out of 60 
Years Active: 2022-2026
Title: Innovations of Theo Odijk in Molecular Patterning
Introduction
Theo Odijk is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of molecular patterning, particularly in the area of nucleic acid molecules. With a total of two patents to his name, Odijk's work is recognized for its potential applications in genomic analysis.
Latest Patents
Odijk's latest patents focus on a system and method for en masse patterning of molecule structures. These patents disclose devices, systems, and methods that utilize microchannels and nanoslits. The microchannels and nanoslits are interconnected by parking chambers. The systems and methods leverage the geometry of the devices in conjunction with a voltage application routine. This allows for the parking of nucleic acid molecules in the parking chambers, followed by their injection into the nanoslits. The methods are designed to present nucleic acid molecules in a manner suitable for genomic analysis and also facilitate size selection of these molecules.
Career Highlights
Throughout his career, Theo Odijk has worked with esteemed organizations such as the Wisconsin Alumni Research Foundation and the University of Leiden. His experience in these institutions has contributed to his expertise in molecular patterning and related technologies.
Collaborations
Odijk has collaborated with notable colleagues, including David Charles Schwartz and Kristy Leigh Kounovsky-Shafer. These collaborations have further enriched his research and innovations in the field.
Conclusion
Theo Odijk's contributions to molecular patterning and nucleic acid analysis are significant. His innovative patents and collaborations highlight his role as a key figure in advancing genomic technologies.